Skip to main content
. 2019 Aug 2;10:830. doi: 10.3389/fphar.2019.00830

Table 3.

Genomic tests covered by Medicare.

Allele FDA CPIC ICUR Willingness-to-pay threshold Type Reference++
MMRgenes $26,000/QALY $50,000/QALY CE (91)
BRCA1/2 3 $9,000/QALY $50,000/QALY CE (Gavan et al., 2018)

3BRCA1/2 testing is regarded as medically necessary only for patients with breast cancer and healthy individuals with a family history of breast cancer. ++Identification number of the article ( Supplementary Table 1 ).